Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
Learn more about the epidemiology, diagnosis, and treatment of advanced systemic mastocytosis in this summary from an expert multidisciplinary case-based discussion.
T-DXd Demonstrates Real-World Efficacy in Advanced Breast Cancer With Dynamic HER2 Expression
Disparities in Survival Outcomes Revealed With BluePrint and MammaPrint Subtyping in HR+/HER2– Breast Cancer
Dr Freeman on Mortality Differences Across Racial Groups in Male Patients With Breast Cancer
Dr Parsons on the Correlation Between Liquid Biopsy and HER2 Status in Breast Cancer
2 Clarke Drive Cranbury, NJ 08512